CSIMarket


Atrion Corporation  (NASDAQ: ATRI)
Other Ticker:  
 

Atrion Corporation

ATRI's Fundamental analysis








Looking into Atrion growth rates, revenue grew by 21.95 % in II. Quarter 2024 from the same quarter a year ago. Ranking at No. 631

Medical Equipment & Supplies industry recorded growth of revenues by 2.42 %

Atrion's net profit decreased by -88.46 % in II. Quarter 2024 year on year, to $0 millions.

More on ATRI's Growth


Atrion
current PE on trailing twelve month basis is above Medical Equipment & Supplies industry average.

Company is currently trading with Price to Cash flow multiple of 203.12 in trailing twelve-month period.
Company
63.7
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 4.46.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.12.


More on ATRI's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 8.75 $
 Dividend Yield TTM (%) 1.91 %
 Revenue/Employee (TTM) $ 255,416
 Net Income/Employee (TTM) $ 17,831
 Receivable Turnover (TTM) 7.37
 Tangible Book Value (Per Share $) 129.40

Atrion
current PE on trailing twelve month basis is above Medical Equipment & Supplies industry average.

Company is currently trading with Price to Cash flow multiple of 203.12 in trailing twelve-month period.
Company
63.7
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 4.46.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.12.

Atrion Price to Book Ratio is at 3.39 higher than Industry Avg. of -460.18, and higher than S&P 500 Avg. of 0.01

More on ATRI's Valuation

  Market Capitalization (Millions $) 811
  Shares Outstanding (Millions) 2
  Employees 712
  Revenues (TTM) (Millions $) 182
  Net Income (TTM) (Millions $) 13
  Cash Flow (TTM) (Millions $) 4
  Capital Exp. (TTM) (Millions $) -18
  Total Debt (Millions $) -
  Dividend TTM ($) 8.75 $
  Dividend Yield TTM (%) 1.91 %
  Revenue/Employee (TTM) $ 255,416
  Net Income/Employee(TTM) $ 17,831
  Receivable Turnover Ratio (TTM) 7.37
  Tangible Book Value (Per Share $) 129.40

  Market Capitalization (Millions $) 811
  Shares Outstanding (Millions) 2
  Employees 712
  Revenues (TTM) (Millions $) 182
  Net Income (TTM) (Millions $) 13
  Cash Flow (TTM) (Millions $) 4
  Capital Exp. (TTM) (Millions $) -18


    ATRI's Profitability Comparisons
Atrion faced margin deterioration, primarily through cost pressure. Operating Margin fell in II. Quarter 2024 to 1.09 % from 6.64 % in I. Quarter.

Atrion net profit margin of 0.82 % is currently ranking no. 60 in Medical Equipment & Supplies industry, ranking no. 186 in Healthcare sector and number 2352 in S&P 500.


Profitability by Segment
Total 0.82 %



  Ratio
   Capital Ratio (MRQ) 6.8
  Total Debt to Equity (MRQ) -
  Tangible Leverage Ratio (MRQ) 0.08
  Asset Turnover Ratio (TTM) 0.69
  Inventory Turnover Ratio (TTM) 1.6



Atrion faced margin deterioration, primarily through cost pressure. Operating Margin fell in II. Quarter 2024 to 1.09 % from 6.64 % in I. Quarter.

Atrion net profit margin of 0.82 % is currently ranking no. 60 in Medical Equipment & Supplies industry, ranking no. 186 in Healthcare sector and number 2352 in S&P 500.

More on ATRI's Key Ratios





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com